| HNSCC | Head and neck squamous cell carcinoma |
| DSG2 | Desmoglein-2 |
| CXCL8 (IL-8) | C-X-C Motif Chemokine Ligand 8 (Interleukin-8) |
| CXCR2 | C-X-C Motif Chemokine Receptor 2 |
| TME | Tumor microenvironment |
| CAF | Cancer-associated fibroblast |
| myCAF | Myofibroblastic cancer-associated fibroblast |
| ICI | Immune checkpoint inhibitor |
| EMT | Epithelial-to-mesenchymal transition |
| MR | Mendelian randomization |
| IVW | Inverse variance-weighted |
| LASSO | Least absolute shrinkage and selection operator |
| TCGA | The Cancer Genome Atlas |
| CPTAC | Clinical Proteomic Tumor Analysis Consortium |
| DepMap | Cancer Dependency Map |
| TF | Transcription factor |
| TIDE | Tumor Immune Dysfunction and Exclusion |
| WGCNA | Weighted gene co-expression network analysis |
| PMN-MDSC | Polymorphonuclear myeloid-derived suppressor cell |
| TIL | Tumor-infiltrating lymphocyte |
| CYT | Cytolytic activity score |
| HPV | Human papillomavirus |